PrEP Readiness Interventions for Supporting Motivation

Part of paid clinical trials in Miami, Florida.

Sponsor
Florida International University
Study ID
NCT04205487
Status
Completed

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Motivational Interviewing (MI) — BEHAVIORAL
    Two motivational interviewing sessions focusing on stimulant use, sexual risk, and PrEP uptake will be delivered via Zoom.
  • Contingency Management (CM) — BEHAVIORAL
    CM will include financial incentives for PrEP clinical evaluation and filling a PrEP prescription.

Study Details

The overarching goal of this formative research is to examine whether, and in what combination, contingency management (CM) and motivational interviewing (MI) can facilitate entry of stimulant-using men who have sex with men (MSM) into the pre-exposure prophylaxis (PrEP) care continuum.

Key Dates

Start date
Oct 16, 2020
Status verified
Jun 2025
Primary completion
Jul 20, 2023
Completion
Jul 28, 2023

Study Design

Enrollment
70 participants (actual)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
PREVENTION

Arms

  • Experimental: Contingency Management (CM) - Only (Non-Responder)
    Non-responders to CM financial inancial incentives for PrEP clinical evaluation and filling a PrEP prescription in Stage 1 that were randomized to assessments only in Stage 2.
  • Experimental: Motivational Interviewing (MI) - Only (Non-Responder)
    Non-responders to two MI sessions focusing on stimulant use, sexual risk, and PrEP use in Stage 1 that were randomized to assessments only in Stage 2
  • Experimental: CM+MI
    Non-responders CM financial incentives for PrEP clinical evaluation and filling a PrEP prescription in Stage 1 that were randomized to receive two sessions of MI in Stage 2.
  • Experimental: MI+CM
    Non-responders to two MI sessions focusing on stimulant use, sexual risk, and PrEP use in Stage 1 that were randomized to receive CM financial incentives for PrEP clinical evaluation and filling a PrEP prescription in Stage 2.
  • Experimental: CM-Only (Responder)
    Respnders to CM financial incentives for CM will include financial incentives for rEP clinical evaluation and filling a PrEP prescription in Stage 1.
  • Experimental: MI-Only (Responder)
    Responders to two MI sessions focusing on stimulant use, sexual risk, and PrEP use will be delivered in Stage 1.

Primary Outcome Measure

Proportion of Participants Filling a Prescription for PrEP [ Time Frame: 6 Months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Miami School of MedicineMiamiFlorida33136-

Find similar trials in Miami, FL

By condition
HIV
By specialty
Infectious disease
By research site
University of Miami School of Medicine· Miami, FL

Related Studies